Thomas E. Hogan - 11 Aug 2026 Form 4 Insider Report for Cellebrite DI Ltd. (CLBT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Aug 2026, 18:17:07 UTC
Prior SEC filing
07 Jul 2026
Next SEC filing
27 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas E. Hogan

Key filing fact

Thomas E. Hogan filed Form 4 for Cellebrite DI Ltd. (CLBT) on 13 Aug 2026.

Key facts

  • This page summarizes Thomas E. Hogan's Form 4 filing for Cellebrite DI Ltd. (CLBT).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Aug 2026, 18:17.

Change

  • Previous filing in this sequence was filed on 07 Jul 2026.
  • Current net transaction value: -$2,149,638.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002013619 Primary reporting owner

Hogan Thomas E.

Relationship
Chief Executive Officer, Director
Address
94 SHLOMO SHMELZER ROAD, PETAH TIKVA, ISRAEL
Signature
/s/ Thomas E. Hogan
Signature date
13 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLBT transaction

Ordinary shares, par value NIS 0.00001

Award

Transaction value
Shares
+339,484
Change %
+57%
Price
$0.000000*
Shares after
930,261
Date
11 Aug 2026
Ownership
Direct
Footnotes
F1
CLBT transaction

Ordinary shares, par value NIS 0.00001

Sale

Transaction value
$2,149,638
Shares
-139,713
Change %
-15%
Price
$15.39
Shares after
790,548
Date
12 Aug 2026
Ownership
Direct
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Thomas E. Hogan is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

Represents ordinary shares of the Issuer delivered pursuant to the terms of performance share awards made to the reporting person on September 19, 2025. The performance-based vesting requirements applicable to such awards were satisfied on August 11, 2026, which represents the date on which the level of performance attained was certified.

Footnote F2

Shares withheld from the vesting and distribution of performance share awards to satisfy the reporting person's tax obligations.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.06 to $15.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .